Sonus Pharmaceuticals Completes Reverse Merger With OncoGenex Technologies

Represented Sonus Pharmaceuticals, Inc. (NAS: SNUS) in its merger with OncoGenex Technologies, Inc. to become OncoGenex Pharmaceuticals. OncoGenex is a biopharmaceutical company focused on cancer treatment resistance, with locations in Washington and British Columbia.